Arkolith/Insider Trading/DSGN/Form 4

William Arsani

DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Aug 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Sell(S)218K$5.25$1.1M1.0M
Aug 13, 2025Sell(S)345K$5.25$1.8M2.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-021842) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML